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Abstract  
Subjects and methods: In this study, the effect of obesity on the development of dyslipidemia, 
hypertension and glucose intolerance among Sudanese adults attending weight reduction programs 
was investigated. According to the BMI (Body mass index), 98 overweight/obese and 60 normal 
weight adults were included. Anthropometric measures were taken, lipid profile and C – reactive 
protein (CRP) were determined using commercial kits. 
Results: Obesity related dyslipidemia seems to affect overweight/obese males more than females. 
On the other hand, overweight /obesity among females, not like males, was found to be associated 
with high blood pressure probably due inflammation, as determined by CRP level. 
Conclusion and recommendation: Obesity related dyslipidemia is more prominent among males 
while obesity related hypertension is a phenomenon among females probably due to release of CRP. 
We recommend a more detailed study of inflammatory cytokines, in relation to obesity, that may 
reflect the mass and/or activity of the adipose tissue. 
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he obesity epidemic is a global public 
health concern that threatens to reduce 
life expectancy around the world1. 
Excess weight; particularly abdominal 
obesity, through reduced adiponectin release 
may cause or exacerbate cardiovascular and 
metabolic risk factors, including 
hypertension, dyslipidemia, and type 2 
diabetes mellitus2. The burden of 
cardiovascular disease (CVD) seems to 
increase lately in nearly all developing 
countries, particularly in urban areas3. It is 
estimated that in the year 2010, CVD will be 
the leading cause of death in these countries3. 
The major causing factor is probably the on-
going nutrition transition with progressive 
shift towards westernized food habits with 
diets high in saturated fats and sugar together 
with more sedentary life style4. The nutrition 
transition has been documented in South 
Africa5. and Gambia6, and Sudan would not 
be an exception. According to previous 
studies, hypertension, diabetes and abnormal 
lipids are related to poor CVD outcomes;  
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including myocardial infarction and stroke 
worldwide and in Africa7. Dyslipidemia has 
emerged as an important CVD risk factor in 
sub-saharan Africa (SSA). In this study, CVD 
risk factors that might be determined by 
obesity were investigated among overweight  
/ obese Sudanese.  
Methods: 
Subjects: 
Ninety eight overweight/obese adult subjects 
(44 men and 54 women of 18 – 62years age 
range) enrolled in different programs of 
weight reduction (diet, exercise, or a 
combination of the two methods), admitted to 
weight reduction centers were involved in this 
study. Sixty age matched controls were also 
included. The study was approved by the 
Ethics Committee of the Sudan Academy for 
Science, and written informed consents were 
obtained from participants before data 
collection. 
A data collection form was completed for 
each participant including age, ethnic group, 
occupation, residence, systolic and diastolic 
blood pressures (SBP, DBP), physical activity 
and programs of weight reduction. Five ml 
fasting venous blood was drawn from each 
participant. Subjects with inflammation or  
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alimentary problems were excluded, as were 
subjects known to suffer diabetes mellitus or 
hypertension. None of the subjects in either 
group was taking medications known to affect 
carbohydrate and lipid metabolism. 
Anthropometric indices: 
Body weight, height, waist and hip 
circumferences were recorded. Waist-hip 
ratio (W/H) and body mass index (BMI) were 
then calculated. Waist was measured with a 
non-stretchable tape over the unclothed 
abdomen at the narrowest point between the 
lowest rib and the iliac crest8. Hip 
circumference (HC) in centimeters was 
measured at the level of the greater trochanter 
using a similar procedure. Two measures 
were made for each index and the average 
was used for analyses. High W/H ratio, 
android pattern of fat distribution, was 
defined as >1.0 for men and >0.85 for 
women9.  
Metabolic variables: 
Using commercial kits, serum total 
cholesterol (TC) (Biosystems, Spain), 
triglyceride (TG) (Liquicolor, Germany), 
High density lipoprotein (HDL) (Spectrum 
diagnostics, Egypt), Low density lipoprotein 
(LDL) (Biosystem, Spain), Blood glucose 
(Crescent diagnostics, KSA) and C-reactive 
protein (Humatex, Germany) were measured 
according to the manufacturers' instructions. 
Statistical analysis: 
The Pearson's Chi-squared test was used for 
comparison and a P-value of <0.05 was 
considered indicative of a statistically 
significant difference. Data analysis was 
performed using the SPSS 13.0 for Windows 
software package (SPSS, Chicago, IL). 
Results:  
In males, the prevalence of abnormal levels of 
TG (more than 150mg /dl ) was 20.83% and 
20% in obese and overweight subjects 
respectively while it was 0% in normal  
weight males (p = 0.03).The prevalence of 
low levels of HDL (less than 40 mg/dl) was 
45.83%, 20% and 6.9% in obese, overweight  
and normal weight subjects, respectively (p = 
0.003). The prevalence of abnormal levels of 
total cholesterol (more than 200mg/dl) tends 
to increase as BMI increases being 0%, 
15%and 41.67% in normal, overweight and 
obese males, (p = 0.000, Table 1). 
 
Table 1:  Prevalence of dyslipidemia and other CVD risk factors among males. 
Risk factor Normal (n=30) Overweight (n=20) Obese (n=24) P value*  
SBP≥130mmHg 1/5 (20%) 6/14 (42.86%) 5/16 (31.25%) 0.614 
DBP≥85mmHg 1/5 (20%) 4/14 (28.57%) 4/16 (25%) 0.928 
FBG ≥110 mg/dl 1/30 (3.44%) 4/20 (20%) 6/24(25%) 0.063 
TG≥150 mg/dl 0/30 (0%) 4/20(20%) 5/24(20.83%) 0.03 
TC ≥200 mg/dl 0/30(0%) 3/20(15%) 10/24(41.67%) 0.000 
HDL ≤40mg/dl 2/30(6.9%) 4/20(20%) 11/24(45.83%) 0.003 
LDL ≥130mg/dl 7/30(24.14%) 9/20(45%) 10/24(41.67%) 0.208 
CRP≥ 8.2 1/30(3.44%) 1/20(4%) 2/24(8.33%) 0.719 
 
 
Among female subjects, the prevalence of 
abnormal levels of CRP ( more than 8.2mg    
/l ) were found to be  26.47% and 10% in 
obese and overweight females, respectively,  
while it was 0% in normal  weight females (p 
= 0.007) The prevalence of elevated SBP 
(more than 130mm Hg) was found to be 50%, 
25%, and 0% in obese, overweight  and 
normal            weight    females   respectively                        
 
(p = 0.001). The prevalence of high DBP 
(more than 85mm Hg) increased with BMI 
being 0%, 25%and 37.5% in normal, 
overweight and obese females, respectively (p 
= 0.004).The prevalence of low HDL 
concentration (less than 50 mg/dl) also 
increases as BMI increases (p = 0.003).  
(Table 2). 
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Table 2: Prevalence of CVD risk factors among females. 
 
Risk factors Normal (n=30) Overweight (n=20) Obese (n=34) P value* 
SBP≥130mmHg 0/30 (0%) 2/8 (25%) 4/8   (50%) 0.001 
DBP≥85mmHg 0/30 (0%) 2/8 (25%) 3/8(37.5%) 0.004 
FBG ≥110 mg/dl 0/30 (0%) 2/20 (10%) 5/34(14.7%) 0.100 
TG≥150 mg/dl 0/30 (0%) 2/20(10%) 3/34(8.82%) 0.225 
Tchol ≥200 mg/dl 1/30(3.33%) 4/20(20%) 2/34(5.88%) 0.09 
HDL ≤ 50mg/dl 0/30(0%) 4/20(20%) 11/24(32.4%) 0.003 
LDL ≥130mg/dl 7/30(23.33%) 7/20(35%) 12/34(35.29%) 0.53 
CRP≥ 8.2 mg/l 0/30(0%) 2/20(10%) 9/34(26.47%) 0.007 
*Pearson's Chi-square test 
 
The frequency of risky SBP (64%) was higher 
among males with gynoid pattern of fat 
distribution compared to those with android 
pattern (23%), p = 0.018.  The pattern of fat 
distribution among males is also affecting the 
frequency of low levels of HDL being 64% 
and 30% among gynoid and android males 
respectively, p = 0.03, (Table 3). 
 
Table 3: Prevalence of CVD risk factors among males with android or gynoid pattern of fat 
distribution:  
Risk factors Android (n=61) Gynoid(n=11) P value* 
SBP≥130mmHg 6/26(23%) 7/11(64%) 0.018 
DBP≥85mmHg 5/26(19.2%) 5/11(45%) 0.100 
FBG ≥110 mg/dl 8/61(13%) 2/11(18%) 0.655 
TG≥150 mg/dl 5/61(8.2%) 3/11(27%) 0.060 
Tchol ≥200 mg/dl 9/61(15%) 3/11(27%) 0.310 
HDL ≤40mg/dl 18/61(30%) 7/11(64%) 0.030 
LDL ≥130mg/dl 23/61(38%) 4/11((36%) 0.933 
CRP≥ 8.2mg/l 3/61(5%) 1/11(9%) 0.578 
*Pearson's Chi-square test 
 
The frequency of risky SBP and DBP was 
higher among females with gynoid pattern of 
fat distribution (57% and 57%, prespectively) 
compared to those with android pattern (22% 
and 11.0%, respectively), p = 0.015 and 0.05,  
 
 
respectively. The pattern of fat distribution 
among females is also affecting the frequency 
of CRP concentration being 22% and 5% 
among gynoid and android females 
respectively (p = 0.017, Table 4).
Table 4: Prevalence of CVD risk factors among females with android or gynoid pattern of fat 
distribution: 
Risk factors Android (n=44) Gynoid (n=41) P value* 
SBP≥130mmHg 2/9(22%) 4/7(57%) 0.015 
DBP≥85mmHg 1/9(11%) 4/7(57%) 0.050 
FBG ≥ 110 mg/dl 2/44(5%) 4/41(10%) 0.350 
TG≥150 mg/dl 1/44(2%) 1/41(2.4%) 0.960 
Tchol ≥200 mg/dl 5/44(11%) 6/44(14%) 0.650 
HDL ≤50mg/dl 3/44(7%) 2/41(5%) 0.700 
LDL≥130mg/dl 12/44(27%) 17/41(41%) 0.168 
CRP≥ 8.2mg/l 2/44(5%) 9/41(22%) 0.017 
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Discussion:  
Prevalence of risky high levels of TG (≥150 
mg/dl), TC (≥200 mg/dl), and low levels of 
HDL (≤40mg/dl) was found to be 
significantly higher among overweight and 
obese males (TG: 20% and 20.3%, TC: 15% 
and 41.6%, HDL: 20% and 45.8%, 
respectively) compared to normal weight 
males (TG: 0.0%, TC: 0.0% and HDL: 
6.9%,). Individuals with greater degrees of 
central adiposity are expected to develop the 
metabolic syndrome more frequently than do 
those with a peripheral body fat distribution10. 
This is consistent with our results since 84.7% 
of males in this study are having android 
pattern of fat distribution. Due to its pro-
atherogenic potential hypertriglyceridemia is 
considered an independent risk factor for 
coronary artery disease11. 
Hypertriacylglyceridemia  increases the 
incidence of cardiovascular disease by 32% in 
men and 76% in women, independent of 
plasma HDL-C levels12. In adults, as in 
children, several ‘adipocytokines’ have been 
related to adiposity indices as well as to 
insulin resistance. Interleukin-6 (IL-6) is one 
of the  inflammatory cytokine released by 
adipose tissue and its level is increased in 
obesity13. IL-6 stimulates the hepatic 
production of C-reactive protein and this can 
explain the state of inflammation associated 
with obesity, and could mediate, at least 
partially, obesity-related insulin resistance13. 
This scenario does not seem to apply to males 
in this study since the mean level of CRP was 
found to be comparable among male groups. 
Insulin resistance has been hypothesized to 
play a major role in dyslipidemia in 
individuals with normal glucose tolerance, as 
well as in those with impaired glucose 
tolerance and type 2 diabetes14. Lipid 
abnormalities have also been reported in 
obese adults, who have elevated triglycerides 
and LDL cholesterol and low levels of HDL 
cholesterol15. Similar lipid profiles have been  
reported in obese and non obese adults with 
type 2 diabetes, in obese normoglycemic 
adults, and in non obese adults with impaired 
glucose tolerance16. According to our results,  
 
 
there is no evidence of glucose intolerance in 
males or females study groups. Therefore, the 
dyslipidemia seen in our male study group is 
not related to release of inflammatory factors 
or the consequent insulin resistance and 
remains to be investigated. In females, not 
like males, obesity seems to affect blood 
pressure and HDL more than other lipids. 
Prevalence of both systolic and diastolic 
hypertension was significantly higher among 
overweight (25% and 25%) and obese (50% 
and 37.5%) compared to normal weight 
females (0.0% and 0.0%). Low levels HDL (≤ 
50mg/dl) were significantly more prevalent 
among overweight and obese compared to 
normal weight females.TG levels of ≥150 
mg/dl were higher among the overweight 
group compared to obese and normal weight 
females, however, differences were not 
significant. In contrast to males, the effect of 
WHR on lipid profiles and blood pressure 
was not evident among females. Normal 
weight females, showing no evidence of 
dyslipidemia or hypertension had comparable 
WHR to obese and both had significantly 
higher WHR than overweight females. 
However, previous reports have shown 
abdominal obesity as positively associated 
with metabolic syndrome in Benin and with 
increased risk of heart disease in Congo17,18. 
In contrast to males among whom the mean 
CRP level, though increases with BMI, does 
not reach to risky high levels as seen among 
females (obese males had mean CRP of 1.64 
mg/l while females had mean CRP of 7.7 
mg/l). This is an indicator of inflammation 
among overweight/obese females in our study 
group. Although the etiology of  hypertension 
is multifactorial, complex and poorly 
understood, nevertheless, recently it has been 
suggested that inflammation of the arterial 
wall is implicated in the development of 
endothelial dysfunction which leads to 
hypertension19. The CRP level has been 
shown to be an independent risk factor for the 
development of hypertension20. The release of 
higher levels of CRP in obese females than 
males in this study may suggest a higher mass 
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and/or more active adipose tissue among 
females compared to males. 
 
Conclusion: 
In conclusion, obesity seems to cause 
dyslipidemia among sudanese adult males but 
not females among whom hypertension is a 
more evident outcome, propably due to 
increased CRP levels. 
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